Response to the Letter to the Editor Re: "Associations between early loss of skeletal muscle and osimertinib trough concentrations in patients with advanced EGFR-mutated NSCLC".

Saved in:
Bibliographic Details
Title: Response to the Letter to the Editor Re: "Associations between early loss of skeletal muscle and osimertinib trough concentrations in patients with advanced EGFR-mutated NSCLC".
Authors: Sikkema BJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, PO Box 2040, Rotterdam 3000 CA, the Netherlands., Veerman M; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, PO Box 2040, Rotterdam 3000 CA, the Netherlands., Hoop EO; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, PO Box 2040, Rotterdam 3000 CA, the Netherlands., Paats MS; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, PO Box 2040, Rotterdam 3000 CA, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, PO Box 2040, Rotterdam 3000 CA, the Netherlands., Dingemans AC; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, PO Box 2040, Rotterdam 3000 CA, the Netherlands. Electronic address: a.dingemans@erasmusmc.nl.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 20; Vol. 244, pp. 116896. Date of Electronic Publication: 2026 Jun 20.
Publication Type: Letter
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2026.116896